2 exciting ASX tech shares to buy

The 2 ASX tech shares in this article are delivering exciting growth and could be worth watching. One idea is Xero Limited (ASX:XRO).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some of the most exciting businesses on the ASX are tech shares. They could be worth thinking about for your portfolio.

Due to the fact that many technology businesses offer an intangible product, it can mean that their gross profit margins may be very high and growth can be quicker.

Technology businesses are attracting a lot of investor intention and these two ideas could be ones to look out for:

Xero Limited (ASX: XRO)

Xero is one of the world's largest cloud accounting software providers. Over the last decade it has taken the approach of heavily re-investing profit and cashflow back into the business to generate more long-term growth.

Over the last five years, Xero has been one of the best performing S&P/ASX 200 Index (ASX: XJO) shares. The ASX tech share has seen its share price grow by 843%. According to the ASX, it now has a market capitalisation that's north of $19 billion.

The company has generated a lot of business growth to get this far. In the FY21 half-year result it said that it had increased its subscriber numbers by another 19% to 2.45 million.

Those subscribers come from all over the world, though Australia is still the biggest market, which saw 21% growth of subscribers to 1.01 million in the latest result. UK subscribers rose 19% to 638,000, New Zealand subscribers increased 13% to 414,000, North American subscribers went up 17% to 251,000 and rest of the world subscribers grew 37% to 136,000.

The global subscriber growth helped operating revenue rise by 21% to NZ$410 million. At 30 September 2020, its annualised monthly recurring revenue had increased to US$877.5 million.

Xero said that it was being disciplined with its financial management during the uncertain COVID-19 period, which led to "strong" growth of net profit, free cash flow and earnings before interest, tax, depreciation and amortisation (EBITDA). The NZ$71.2 million increase in operating revenue led to a NZ$49.4 million increase in free cashflow for the ASX tech share. This is helped by the fact that Xero's gross profit margin is now 85.7%.

In a signal that Xero isn't anywhere near finished with its growth journey, it stated that it still has ambitions for high growth and it intends to continue to innovate, invest in new products and customer growth, and respond to opportunities.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara is a business that provides an integrated breast health platform which helps provide feedback and also aims to help prevent advanced-stage breast cancer.

This business is another one with a very high gross profit margin. In the FY21 half-year result it reported that its gross margin was 92%. That report showed that revenue rose by 38%, subscription revenue increased 71% and gross profit increased by 43%.

At the time of the half-year result, it had NZ$19.9 million of annual recurring revenue (ARR) and approximately 27% of women in the US had a Volpara product applied on their images and data.

The ASX tech share then released its FY21 third quarter result which showed ARR had risen to NZ$20.7 million and its average revenue per user (ARPU) grew 5% to US$1.22.

A couple of weeks ago, Volpara announced it was acquiring CRA Health in the US for an upfront payment of US$18 million. This acquisition increases Volpara's market share to over 30% of US breast screenings, it increases the ARR to NZ$26.9 million and is likely to increase the ARPU of the business as well.

Management believe that this deal has elevated the company to be a leader in personalised breast care and could spur more growth because CRA's software is integrated with the major electronic health record (EHR) as well as with genetics companies.

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia owns shares of Xero. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Technology Shares

A young man punches the air in delight as he reacts to great news on his mobile phone.
Technology Shares

3 ASX tech stocks that brokers rate as buys

Let's see which shares are being recommended by analysts this month.

Read more »

Red buy button on an Apple keyboard with a finger on it.
AI Stocks

3 reasons to buy NextDC shares today

A leading investment analyst says NextDC shares are well-positioned to outperform. But why?

Read more »

A couple are shocked and elated at the good news they've just seen on their devices.
Technology Shares

Why are Life360 shares soaring 10% higher today?

The ASX tech stock is just 2% lower than this time last year.

Read more »

Military soldier standing with army land vehicle as helicopters fly overhead.
Technology Shares

If you think global instability will persist, these ASX ETFs might be for you

It's possible to get global exposure to defence while investing on the ASX.

Read more »

Worried young woman doing banking and administrative work with hands on head.
Technology Shares

Have ASX technology shares finally hit rock bottom?

Is now finally the time to buy low?

Read more »

Doctor checking patient's spine x-ray image.
Technology Shares

Pro Medicus shares fall after market selloff overshadows $40 million contract news

Let's see what this growing company has announced this morning.

Read more »

Nervous customer in discussions at a bank.
Technology Shares

What to make of Xero's 12% recovery last week?

Recovery on the way or time to sell?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Technology Shares

Could DroneShield shares double again in 2026?

Let's see if this market darling could keep rising.

Read more »